Previous Page  15 / 36 Next Page
Information
Show Menu
Previous Page 15 / 36 Next Page
Page Background

Page 64

Euro Cancer 2018

Day 2 July 24, 2018

Sessions:

Clinical Oncology | Chemotherapy | Cancer Screening

Session Chair

Jaime Tisnado

Virginia Commonwealth University, USA

Session Chair

Kang-Yell Choi

Yonsei University, South Korea

Title:

In vivo

quantitation of circulating tumor cells with high-speed confocal microscopy in mouse

tumor model

Howon Seo,

Korea Advanced Institute of Science and Technology, South Korea

Title:

A new disulfide-stabilized diabody against bFGF and the inhibition of cancer

Ning Deng,

Jinan University, China

Title:

Through which pathway does Trastuzumab and miR-122-5p combinatorial administration

lead breast cancer cells to apoptosis: Intrinsic or extrinsic pathway?

Sercan Ergun,

Ordu University, Turkey

Title:

Investigation of piR-36707 and piR-36741 expression levels in renal cell (Transparent Cell

Type) carcinomas

Diler Us Atlay,

Ordu University, Turkey

Title:

Leptin receptor antagonist as a potent histone deacetylases (HDACs) inhibitor in ovarian

cancer cells

Ewa L Gregoraszczuk,

University in Kraków, Poland

Title:

Comparing BRAF mutation status in corresponding primary and metastatic cutaneous

melanomas: Implications on optimized targeted therapy

Ibrahim Khalifeh,

American University of Beirut Medical Center, Lebanon

Session Introduction